• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Are you drinking the kool aid?

Anonymous

Guest
A word of advice do not trust a single soul within our company. Your "friend" HR is extension of your boss, and, ONLY has companies best interest in mind and will look to mitigate risk at any cost EVEN if you are right.

HR will befriend you, and, follow it up by placing a 12 inch knife right in the middle of your back.

It's sad that we have to work in an environment like this what a sorry state of affairs.